Status:
UNKNOWN
A Study Using L5 as a Risk Factor of Cardiovascular (CV) Disease in Chronic Renal and Dialytic Patients
Lead Sponsor:
China Medical University Hospital
Conditions:
Cardiovascular Disease
Chronic Kidney Disease Patients
Eligibility:
All Genders
20+ years
Brief Summary
The purpose of this study is to determine whether L5, one of the Low Density Lipoproteins, is an effective predicting factor for cardiovascular disease in chronic renal and hemodialytic patients.
Detailed Description
Cardiovascular disease (CVD) is the most important cause of death of chronic kidney disease (CKD) and hemodialysis (HD) patients. Low Density Lipoprotein (LDL) is an essential indicator of CVD.The hig...
Eligibility Criteria
Inclusion
- clinical diagnosis of CKD
- clinical diagnosis of HD
Exclusion
- N/A
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT01236820
Start Date
September 1 2010
Last Update
November 9 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China Medical University Hospital
Taichung, Taiwan, Taiwan, 404